account_id none on file
legal_name Lisata Therapeutics, Inc.
ticker LSTA
cik 320017
domain lisata.com
linkedin_company_url https://www.linkedin.com/company/lisatatx/
entry_point_account_id none on file
name Lisata Therapeutics Inc.
exchange Nasdaq
sector Health Care
hq Basking Ridge, NJ, United States
sector index/company/sector/health-care/
calls 1 filings 3 executives 8 family 0
why_nownone on file
calls
This was primarily due to savings resulting from the elimination of an employee position and lower spend on consulting and travel and entertainment expenses.
Aug 7, 2025 / receipt, needs a key / James Nisko, CFO | earnings call 2025-08-07 | transcript ca49631f-e8bf-4de2-94e6-b265d37f1113 | chars 5609-5766 | segment 5
filings
Reduction in Force On August 3, 2026, our board of directors (the “Board”) approved a reduction in workforce by approximately 72%, effective immediately.
filing / Aug 6, 2026 / receipt
As a result of our reduction in force of approximately 72% of our employees, we estimate that we will incur approximately $1.2 million of costs in connection with the reduction in workforce related to severance pay and other related termination benefits.
filing / Aug 6, 2026 / receipt
partially offset by severance costs in the prior year and lower equity expense in the current year. Historically, to minimize our use of cash, we have used a variety of equity instruments to compensate employees, consultants and other service providers.
filing / May 11, 2026 / receipt
executives
| D. Greenacre Martyn D. Greenacre | Chairman | - | receipt |
| David Slack | President and Chief Business Officer | - | receipt |
| James Nisco | Senior Vice President, Finance and Treasury and Chief Accounting Officer | receipt | |
| James Nisko | CFO | - | receipt |
| Joseph Talamo | Vice President | - | receipt |
| Martin Schmieg | Vice President | - | receipt |
| Robert Dickey IV | Chief Financial Officer | - | receipt |
| Stephen W. Potter | Executive Vice President | - | receipt |
familynone on file
upcoming
| 2026-11-05 | earnings call | scheduled | ir |
changes
| 2024-04-17 | Senior Vice President, appointed | sec_8k |
| 2022-09-15 | President and Chief Business Officer, appointed | sec_8k |
| 2016-12-30 | director, departed | sec_8k |
| 2015-12-23 | Chairman, departed | sec_8k |
| 2013-08-19 | Chief Financial Officer, appointed | sec_8k |
| 2013-07-19 | Executive Vice President, appointed | sec_8k |
| 2012-07-09 | Vice President, appointed | sec_8k |
| 2011-12-09 | Chairman, appointed | sec_8k |
| 2011-06-30 | Vice President, appointed | sec_8k |
mcp_package_hint
slug lisata-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$